Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
US10758514B2 · kind B2 · utility
19Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2018 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | May 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.